|
TSR1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.60202970281398E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.68964842117703E-12 |
| Normal-vs-Stage2 |
4.760300E-04 |
| Normal-vs-Stage3 |
1.52733999999599E-05 |
| Normal-vs-Stage4 |
2.049200E-04 |
| Stage1-vs-Stage2 |
2.074200E-01 |
| Stage1-vs-Stage3 |
1.021600E-01 |
| Stage1-vs-Stage4 |
1.717970E-01 |
| Stage2-vs-Stage3 |
9.988800E-01 |
| Stage2-vs-Stage4 |
9.758400E-01 |
| Stage3-vs-Stage4 |
9.700800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.67774691309342E-12 |
| Normal-vs-AfricanAmerican |
5.084600E-03 |
| Normal-vs-Asian |
1.571050E-04 |
| Caucasian-vs-AfricanAmerican |
1.830230E-01 |
| Caucasian-vs-Asian |
5.115000E-01 |
| AfricanAmerican-vs-Asian |
2.508200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.8945995013745E-10 |
| Normal-vs-Female |
7.2597483580239E-13 |
| Male-vs-Female |
3.479600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.041190E-01 |
| Normal-vs-Age(41-60Yrs) |
1.88099535947117E-11 |
| Normal-vs-Age(61-80Yrs) |
5.69060354393969E-11 |
| Normal-vs-Age(81-100Yrs) |
1.430050E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.343000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.810400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.780800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.795000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.438200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.889000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.629500E-04 |
| Normal-vs-Grade 2 |
2.01605399041682E-12 |
| Normal-vs-Grade 3 |
5.91710003217116E-09 |
| Normal-vs-Grade 4 |
1.775480E-03 |
| Grade 1-vs-Grade 2 |
1.449410E-01 |
| Grade 1-vs-Grade 3 |
6.493900E-02 |
| Grade 1-vs-Grade 4 |
5.721900E-02 |
| Grade 2-vs-Grade 3 |
1.723780E-01 |
| Grade 2-vs-Grade 4 |
8.115800E-02 |
| Grade 3-vs-Grade 4 |
4.591600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62436730732907E-12 |
| Normal-vs-ccB subtype |
1.76329999999059E-05 |
| ccA subtype-vs-ccB subtype |
5.90670000000237E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.60700033677597E-10 |
| Normal-vs-N1 |
9.881100E-03 |
| N0-vs-N1 |
1.975810E-01 |
|
|
